Has Delta killed the herd immunity dream?
As the Delta variant continues its global surge, experts are questioning whether the long-held goal of achieving herd immunity from Covid-19 through vaccination is still viable
UK facing supply crunch thanks to Covid and Brexit
Britain's factories, restaurants and supermarkets are facing stubborn supply problems due to the Covid pandemic and Brexit, sparking calls this week for government help ahead of Christmas
Slow Covid vaccination to cost global economy $2.3 tn: study
The slow rollout of coronavirus vaccines will cost the global economy $2.3 trillion in lost output, according to the Economist Intelligence Unit
Five billion Covid shots: a state of play worldwide
More than five billion anti-Covid jabs have been given globally, but wide disparities between rich and poor countries in access to vaccines persist
Suspect Afghan evacuees put focus on European security screening
The discovery of Afghan evacuees representing potential security risks in France and Britain has put the spotlight on screening efforts during the evacuation operation
Goodbye plastic, hello alternatives!
Many single-use plastic items were banned on 3rd of July. Here are a few alternatives and how sustainable they are. Drag the items to the right category...
EU chief appeals to members: take in Afghan refugees
EU chief Ursula von der Leyen has appealed to European Union states to take in Afghan refugees flown out from Kabul, promising financial support from Brussels
Kabul airlift gathers pace as harrowing stories emerge
The emergency airlift from Kabul of both foreign nationals and Afghans who worked with them is gathering pace as more detail of the desperation and fear driving the rescues emerges
Pharmaceutical firms rake in billions with Covid jabs
Some of the world's largest pharmaceutical companies have released their latest financial results which show how the Covid vaccines have added billions to their coffers
Health passes spread around the world
Passes and vaccine passports are increasingly being used across the world to limit entry to public places to those who have been vaccinated, recovered from Covid-19 or tested negative
- 1
- 2